Article Information
History
- March 12, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Min Hyung Kim, MD, PhD1,¶,
- Yooju Nam, MD2,¶,
- Nak-Hoon Son, PhD3,¶,
- Namwoo Heo, MD1,
- Bongyoung Kim, MD, PhD4,
- Eawha Kang, MD, PhD2,
- Areum Shin, MD2,
- Andrew Jihoon Yang, MD2,
- Yoon Soo Park, MD, PhD1,
- Heejung Kim, MD, PhD5,
- Taeyoung Kyong, MD2,* and
- Yong Chan Kim, MD, PhD1,*
- 1Department of Internal Medicine, Division of Infectious disease, Yongin Severance Hospital, Yonsei University College of Medicine, 363 Dongbaekjukjeon-daero, Giheung-gu, Yongin-si, Gyeonggi-do 16995, Republic of Korea
- 2Department of Hospital Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, 363 Dongbaekjukjeon-daero, Giheung-gu, Yongin-si, Gyeonggi-do 16995, Republic of Korea
- 3Department of Statistics, Keimyung University, 104 Myeongdeak-ro, Nam-gu, Daegu-si, Gyeongsangbuk-do 42403, Republic of Korea
- 4Department of Internal Medicine, Hanyang University College of Medicine, 222-1 Wangsimni-ro, Seongdong-gu, Seoul 04763, Republic of Korea
- 5Department of Laboratory Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, 363 Dongbaekjukjeon-daero, Giheung-gu, Yongin-si, Gyeonggi-do 16995, Republic of Korea
- ↵*Corresponding author: Yong Chan Kim, Division of Infectious Diseases, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, 363 Dongbaekjukjeon-daero, Giheung-gu, Yongin-si, Gyeonggi-do 16995, Republic of Korea, Phone: +82-10-8538-2389, E-mail: amomj{at}yuhs.ac, Yong Chan Kim and Taeyoung Kyong contributed equally as corresponding authors.
↵¶ Min Hyung Kim, Yooju Nam, and Nak-Hoon Son contributed equally to this manuscript.
Posted March 12, 2022.
Vaccine-induced antibody level predicts the clinical course of breakthrough infection of COVID-19 caused by delta and omicron variants: a prospective observational cohort study
